c-MYC anticorps (AA 257-439)
Aperçu rapide pour c-MYC anticorps (AA 257-439) (ABIN3043598)
Antigène
Voir toutes c-MYC (MYC) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 257-439
-
Fonction
- Anti-c-Myc Antibody
-
Specificité
- No cross reactivity with other proteins.
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Homologie
- Human c-Myc shares 91% amino acid (aa) sequences identity with both mouse,rat c-Myc.
-
Attributs du produit
- Anti-c-Myc Antibody. Tested in IF, ICC, WB applications. This antibody reacts with Human, Mouse, Rat.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived human c-Myc recombinant protein (Position: E257-A439). Human c-Myc shares 91% amino acid (aa) sequences identity with both mouse and rat c-Myc.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Western blot, 0.1-0.5 μg/mL, Human, Mouse, Rat Immunocytochemistry/Immunofluorescence, 5 μg/mL, Human
-
Commentaires
-
Antibody can be supported by chemiluminescence kit ABIN921124 in WB.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl and 0.2 mg Na2HPO4.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles. -
Date de péremption
- 12 months
-
-
-
: "The novel protein C9orf116 promotes rat liver cell line BRL-3A proliferation." dans: PLoS ONE, Vol. 12, Issue 7, pp. e0180607, (2017) (PubMed).
: "The novel protein C3orf43 accelerates hepatocyte proliferation." dans: Cellular & molecular biology letters, Vol. 22, pp. 21, (2017) (PubMed).
: "LiCl inhibits PRRSV infection by enhancing Wnt/?-catenin pathway and suppressing inflammatory responses." dans: Antiviral research, Vol. 117, pp. 99-109, (2015) (PubMed).
: "Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3? (GSK-3?) ..." dans: European journal of medicinal chemistry, Vol. 86, pp. 165-74, (2014) (PubMed).
: "Litopenaeus vannamei sterile-alpha and armadillo motif containing protein (LvSARM) is involved in regulation of Penaeidins and antilipopolysaccharide factors." dans: PLoS ONE, Vol. 8, Issue 2, pp. e52088, (2013) (PubMed).
: "Down-regulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC." dans: PLoS ONE, Vol. 8, Issue 10, pp. e77829, (2013) (PubMed).
: "Leptin induces cell proliferation and reduces cell apoptosis by activating c-myc in cervical cancer." dans: Oncology reports, Vol. 29, Issue 6, pp. 2291-6, (2013) (PubMed).
: "HILI inhibits TGF-? signaling by interacting with Hsp90 and promoting T?R degradation." dans: PLoS ONE, Vol. 7, Issue 7, pp. e41973, (2012) (PubMed).
: "RPB5-mediating protein is required for the proliferation of hepatocellular carcinoma cells." dans: The Journal of biological chemistry, Vol. 286, Issue 13, pp. 11865-74, (2011) (PubMed).
: "Effects of matrine on HepG2 cell proliferation and expression of tumor relevant proteins in vitro." dans: Pharmaceutical biology, Vol. 48, Issue 3, pp. 275-81, (2010) (PubMed).
: "Osteogenic role of endosomal chloride channels in MC3T3-E1 cells." dans: Molecular and cellular biochemistry, Vol. 342, Issue 1-2, pp. 191-9, (2010) (PubMed).
: "Molecular cloning, expression and subcellular distribution of an alternative splice variant of the porcine Sirt2 gene." dans: Molecular biology reports, Vol. 37, Issue 3, pp. 1671-6, (2010) (PubMed).
: "Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer." dans: Oncology reports, Vol. 22, Issue 5, pp. 1189-95, (2009) (PubMed).
-
-
- c-MYC (MYC) (Myc Proto-Oncogene protein (MYC))
-
Autre désignation
- MYC
-
Sujet
-
Background: C-Myc is an oncogene that functions both in the stimulation of cell proliferation and in apoptosis. C-Myc elicits its oncogenic activity by causing immortalization, and to a lesser extent the transformation of cells, in addition to several other mechanisms. The c-MYC proto-oncogene encodes a transcription factor that is critical for cell growth and proliferation. It is one of the genes frequently altered in cancer cells in which it exhibits constitutive activity. Downregulation of c-Myc is critical for 2-Methoxyestradiol (2ME2)-induced oxidative stress and apoptosis in AML cells. And its up-regulation is important for promoting lymphocyte cell division, and demonstrating that GFP-c-Myc expression is a marker of proliferating lymphocytes in vivo.
Gene Full Name: MYC proto-oncogene, bHLH transcription factor
Sequence Similarities: Contains 1 bHLH (basic helix-loop-helix) domain.
-
Poids moléculaire
- 60-65 kDa
-
ID gène
- 4609
-
UniProt
- P01106
-
Pathways
- Signalisation p53, Cycle Cellulaire, Sensory Perception of Sound, Transition Metal Ion Homeostasis, Mitotic G1-G1/S Phases, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus, L'effet Warburg
Antigène
-